טוען...
Challenges and opportunities for the subcutaneous delivery of therapeutic proteins
Biotherapeutics are a rapidly growing drug class and well over 200 biotherapeutics have already obtained approval, with about fifty of these being approved in 2015 and 2016 alone (1). Several hundred protein therapeutic products are still in the pipeline, including interesting new approaches to trea...
שמור ב:
| הוצא לאור ב: | J Pharm Sci |
|---|---|
| Main Authors: | , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2018
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5915922/ https://ncbi.nlm.nih.gov/pubmed/29336981 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.xphs.2018.01.007 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|